UPN1826_HM2794_S26_L002_R1_001.fastq.gz

syn25931924

Created By Elliot Stieglitz estieglitz

age: 2.5
sex: Male
Uuid: 89cbcc00-79dd-4cef-9a0d-39bbfdd826a9
assay: bisulfite sequencing
organ:
tissue: blood
ageUnit: months
runType: pairedEnd
species: Homo sapiens
studyId: syn51133946
comments:
dataType: chromatin activity
entityId: syn25931924
platform: Illumina NovaSeq 6000
readPair: 1
Component: EpigeneticsAssayTemplate
aliquotID:
diagnosis:
readDepth:
studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial
tumorType: Juvenile Myelomonocytic Leukemia
fileFormat: fastq
initiative: DHART-SPORE Project 3
isCellLine: No
readLength: 150
specimenID: UPN1826_HM2794
assayTarget:
dataSubtype: raw
nf1Genotype: Unknown
nf2Genotype: Unknown
individualID: UPN1826_HM2794
resourceType: experimentalData
fundingAgency: NIH-NCI
isPrimaryCell: Yes
timePointUnit:
parentSpecimenID: UPN1826_HM2794
nucleicAcidSource: bulk cell
dissociationMethod:
genePerturbationType: Not Applicable
experimentalTimepoint:
specimenPreparationMethod:
genePerturbationTechnology:

UPN1826_HM2794_S26_L002_R1_001.fastq.gz page is loading…